1. Scrip code : 524348
Name : Aarti Drugs Limited
Subject : Corporate Action-Board recommends Bonus Issue
We wish to inform you that Board of Directors at its Meeting held on Thursday, August 20, 2020 has approved the following subject to approval of the Shareholders (through Postal Ballot and e-voting): a) Increase in authorized share capital of the Company from Rs. 25,00,00,000/- (Rupees Twenty Five Crore) to Rs. 120,00,00,000/- (Rupees One hundred and Twenty Crores) by creation of additional 9,50,00,000 (Nine Crores Fifty Lakhs) Equity Shares of Rs. 10/- (Rupees Ten only) each and consequent amendment to clause V of the Memorandum of Association of the Company. b) the issuance of fully paid up Bonus Share in the ratio of 3:1 i.e. 3 (Three) Bonus Equity Share of Rs. 10/- each for 1 (One) fully paid up Equity Share of Rs. 10/- each. The Company will intimate the ‘Record Date’ for determining eligible Shareholders entitled to receive Bonus Shares in due course.
2. Scrip code : 500207
Name : Indo Rama Synthetics (India) Ltd.,
Subject : Withdrawal Of Disclosure Given Under Regulation 10(5) Of The SEBI (Substantial Acquisition Of Shares And Takeover) Regulations, 2011
This is to inform that the Company had earlier received an intimation in relation to the proposed acquisition of 5,35,64,057 equity shares held by Brookgrange Investments Limited in Indo Rama Synthetics (India) Limited by another Promoter Mr. Aloke Lohia, and a disclosure under Regulation 10(5) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011 was filed vide a letter dated 11 August 2020. Further, we wish to inform that the Company has now received a letter dated 31st August 2020 from Mr. Aloke Lohia (the ‘Acquirer’) intimating the withdrawal of the above-stated proposed acquisition and the disclosure given under Regulation 10(5) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011, vide a letter dated 11 August 2020.